Search Results - Haizhou Xing
- Showing 1 - 5 results of 5
-
1
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy by Weijie Cao, Haizhou Xing, Yingmei Li, Wenliang Tian, Yongping Song, Zhongxing Jiang, Jifeng Yu
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives by Hao Sun, Yingmei Li, Peng Zhang, Haizhou Xing, Song Zhao, Yongping Song, Dingming Wan, Jifeng Yu
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives by Hao Sun, Yingmei Li, Peng Zhang, Haizhou Xing, Song Zhao, Yongping Song, Dingming Wan, Jifeng Yu
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
WITHDRAWN: SPOP Promotes Acute Myeloid Leukemia Initiation and Development Through miR-183-Mediated METAP2 Inhibition by Jifeng Yu, Yingmei Li, Ling Sun, Lijie Han, Yu Liu, Danfeng Zhang, Haizhou Xing, Xinsheng Xie, Dingming Wan, Zhongxing Jiang
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment by Rongqun Guo, Mengdie Lü, Fujiao Cao, Guanghua Wu, Fengcai Gao, Haili Pang, Yadan Li, Yinyin Zhang, Haizhou Xing, Chunyan Liang, Tianxin Lyu, Chunyan Du, Yingmei Li, Rong Guo, Xinsheng Xie, Wei Li, Delong Liu, Yongping Song, Zhongxing Jiang
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book